Joel Greenblatt Adaptive Biotechnologies Corp Transaction History
Gotham Asset Management, LLC
- $11.5 Billion
- Q1 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 10,693 shares of ADPT stock, worth $130,454. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,693Holding current value
$130,454% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ADPT
# of Institutions
254Shares Held
152MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$366 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$160 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$136 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$81 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.74B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...